Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3

Sainan Li, Yujing Xia, Kan Chen, Jingjing Li, Tong Liu, Fan Wang, Jie Lu, Yingqun Zhou, Chuanyong Guo Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China Background: Epigallocatechin-3-gallat...

Full description

Bibliographic Details
Main Authors: Li S, Xia Y, Chen K, Li J, Liu T, Wang F, Lu J, Zhou Y, Guo C
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/epigallocatechin-3-gallate-attenuates-apoptosisnbspand-autophagy-in-co-peer-reviewed-article-DDDT
id doaj-8a0ad2ec9a22429bb0d4682928ed75fd
record_format Article
spelling doaj-8a0ad2ec9a22429bb0d4682928ed75fd2020-11-24T21:02:14ZengDove Medical PressDrug Design, Development and Therapy1177-88812016-02-012016Issue 163164725583Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3Li SXia YChen KLi JLiu TWang FLu JZhou YGuo CSainan Li, Yujing Xia, Kan Chen, Jingjing Li, Tong Liu, Fan Wang, Jie Lu, Yingqun Zhou, Chuanyong Guo Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China Background: Epigallocatechin-3-gallate (EGCG) is the most effective compound in green tea, and possesses a wide range of beneficial effects, including anti-inflammatory, antioxidant, antiobesity, and anticancer effects. In this study, we investigated the protective effects of EGCG in concanavalin A (ConA)-induced hepatitis in mice and explored the possible mechanisms involved in these effects.Methods: Balb/C mice were injected with ConA (25 mg/kg) to induce acute autoimmune hepatitis, and EGCG (10 or 30 mg/kg) was administered orally twice daily for 10 days before ConA injection. Serum liver enzymes, proinflammatory cytokines, and other marker proteins were determined 2, 8, and 24 hours after the ConA administration.Results: BNIP3 mediated cell apoptosis and autophagy in ConA-induced hepatitis. EGCG decreased the immunoreaction and pathological damage by reducing inflammatory factors, such as TNF-α, IL-6, IFN-γ, and IL-1β. EGCG also exhibited an antiapoptotic and antiautophagic effect by inhibiting BNIP3 via the IL-6/JAKs/STAT3 pathway.Conclusion: EGCG attenuated liver injury in ConA-induced hepatitis by downregulating IL-6/JAKs/STAT3/BNIP3-mediated apoptosis and autophagy. Keywords: concanavalin A, hepatitis, EGCG, autophagy, apoptosis, BNIP3, STAT3, JAKs, IL-6https://www.dovepress.com/epigallocatechin-3-gallate-attenuates-apoptosisnbspand-autophagy-in-co-peer-reviewed-article-DDDTConcanavalin AhepatitisEGCGautophagyapoptosisBNIP3STAT3JAKsIL-6.
collection DOAJ
language English
format Article
sources DOAJ
author Li S
Xia Y
Chen K
Li J
Liu T
Wang F
Lu J
Zhou Y
Guo C
spellingShingle Li S
Xia Y
Chen K
Li J
Liu T
Wang F
Lu J
Zhou Y
Guo C
Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
Drug Design, Development and Therapy
Concanavalin A
hepatitis
EGCG
autophagy
apoptosis
BNIP3
STAT3
JAKs
IL-6.
author_facet Li S
Xia Y
Chen K
Li J
Liu T
Wang F
Lu J
Zhou Y
Guo C
author_sort Li S
title Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
title_short Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
title_full Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
title_fullStr Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
title_full_unstemmed Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
title_sort epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin a-induced hepatitis by inhibiting bnip3
publisher Dove Medical Press
series Drug Design, Development and Therapy
issn 1177-8881
publishDate 2016-02-01
description Sainan Li, Yujing Xia, Kan Chen, Jingjing Li, Tong Liu, Fan Wang, Jie Lu, Yingqun Zhou, Chuanyong Guo Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China Background: Epigallocatechin-3-gallate (EGCG) is the most effective compound in green tea, and possesses a wide range of beneficial effects, including anti-inflammatory, antioxidant, antiobesity, and anticancer effects. In this study, we investigated the protective effects of EGCG in concanavalin A (ConA)-induced hepatitis in mice and explored the possible mechanisms involved in these effects.Methods: Balb/C mice were injected with ConA (25 mg/kg) to induce acute autoimmune hepatitis, and EGCG (10 or 30 mg/kg) was administered orally twice daily for 10 days before ConA injection. Serum liver enzymes, proinflammatory cytokines, and other marker proteins were determined 2, 8, and 24 hours after the ConA administration.Results: BNIP3 mediated cell apoptosis and autophagy in ConA-induced hepatitis. EGCG decreased the immunoreaction and pathological damage by reducing inflammatory factors, such as TNF-α, IL-6, IFN-γ, and IL-1β. EGCG also exhibited an antiapoptotic and antiautophagic effect by inhibiting BNIP3 via the IL-6/JAKs/STAT3 pathway.Conclusion: EGCG attenuated liver injury in ConA-induced hepatitis by downregulating IL-6/JAKs/STAT3/BNIP3-mediated apoptosis and autophagy. Keywords: concanavalin A, hepatitis, EGCG, autophagy, apoptosis, BNIP3, STAT3, JAKs, IL-6
topic Concanavalin A
hepatitis
EGCG
autophagy
apoptosis
BNIP3
STAT3
JAKs
IL-6.
url https://www.dovepress.com/epigallocatechin-3-gallate-attenuates-apoptosisnbspand-autophagy-in-co-peer-reviewed-article-DDDT
work_keys_str_mv AT lis epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT xiay epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT chenk epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT lij epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT liut epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT wangf epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT luj epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT zhouy epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
AT guoc epigallocatechin3gallateattenuatesapoptosisnbspandautophagyinconcanavalinainducedhepatitisbyinhibitingbnip3
_version_ 1716776084906704896